Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03947255 · OUTCOME

Rate of Complete Response (CR) Per BICR According to Modified Lugano Response Criteria

A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma · Source last updated 2023-10-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage of Participants
Interval / dispersion
95% Confidence Interval
Time frame
Up to 18.3 months

What was measured

CR rate is defined as the percentage of participants with CR according to the modified Lugano Criteria for Response Assessment (Cheson 2014)

Analysis population: The full analysis set includes participants who received at least one dose of study treatment.

Groups in this outcome

Classic Hodgkin Lymphoma

Participants with classic Hodgkin lymphoma

PTCL

Participants with peripheral T cell lymphoma

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Classic Hodgkin Lymphoma5
PTCL6

Reported measurements

Source class 1
Values in Percentage of Participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Classic Hodgkin Lymphoma20.0Not reported0.571.6Not reported
PTCL66.7Not reported22.395.7Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.5
        upper Limit
        71.6
        value
        20.0
      2. group Id
        OG001
        lower Limit
        22.3
        upper Limit
        95.7
        value
        66.7
denoms
  1. counts
    1. group Id
      OG000
      value
      5
    2. group Id
      OG001
      value
      6
    units
    Participants
description
CR rate is defined as the percentage of participants with CR according to the modified Lugano Criteria for Response Assessment (Cheson 2014)
dispersion Type
95% Confidence Interval
groups
  1. description
    Participants with classic Hodgkin lymphoma
    id
    OG000
    title
    Classic Hodgkin Lymphoma
  2. description
    Participants with peripheral T cell lymphoma
    id
    OG001
    title
    PTCL
param Type
NUMBER
population Description
The full analysis set includes participants who received at least one dose of study treatment.
reporting Status
POSTED
time Frame
Up to 18.3 months
title
Rate of Complete Response (CR) Per BICR According to Modified Lugano Response Criteria
type
SECONDARY
unit Of Measure
Percentage of Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice